{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:07:31Z","timestamp":1767845251193,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.jim.2008.01.007","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T12:05:37Z","timestamp":1202731537000},"page":"89-106","source":"Crossref","is-referenced-by-count":67,"title":["Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization"],"prefix":"10.1016","volume":"333","author":[{"given":"Han","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Soroka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Thomas H.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Stamey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly Wallace","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison E.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darbi R.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li X.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Wade","family":"Oxford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Caba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Pleatman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera A.","family":"Semenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia P.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2008.01.007_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01794","article-title":"Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin","volume":"424","author":"Agrawal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jim.2008.01.007_bib1","doi-asserted-by":"crossref","first-page":"26165","DOI":"10.1016\/S0021-9258(18)47173-6","article-title":"Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells","volume":"269","author":"Arora","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2008.01.007_bib2","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"11","author":"Albrecht","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2006.07.002","article-title":"Anthrax toxins: a paradigm of bacterial immune suppression","volume":"27","author":"Baldari","year":"1996","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jim.2008.01.007_bib3","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"Neisseria meningitidis group B correlates of protection and assay standardization\u2014international meeting report Emory University, Atlanta, Georgia, United States, 16\u201317 March 2005","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib4","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2008.01.007_bib48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/510856","article-title":"Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model","volume":"195","author":"Cui","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2008.01.007_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jim.2008.01.007_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/IAI.45.3.761-767.1984","article-title":"Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin","volume":"45","author":"Ezzell","year":"1984","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib8","unstructured":"Food and Drug Administration, 1999. Guidance for Industry: Validation of Analytical Procedures: Methodology: Final Guidance. Found at http:\/\/www.fda.gov\/cvm\/Guidance\/guida64.htm"},{"key":"10.1016\/j.jim.2008.01.007_bib9","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process","volume":"261","author":"Friedlander","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2008.01.007_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.61.1.245-252.1993","article-title":"Characterization of macrophage sensitivity and resistance to anthrax lethal toxin","volume":"61","author":"Friedlander","year":"1993","journal-title":"Infect Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib11","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2958.1999.01137.x","article-title":"Germination of Bacillus anthracis spores within alveolar macrophages","volume":"31","author":"Guidi-Rontani","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jim.2008.01.007_bib12","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1073\/pnas.90.21.10198","article-title":"On the role of macrophages in anthrax","volume":"90","author":"Hanna","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2008.01.007_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","article-title":"Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill","volume":"119","author":"Hansen","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2008.01.007_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CVI.13.2.208-213.2006","article-title":"Neutralizing antibodies and persistence of immunity following anthrax vaccination","volume":"13","author":"Hanson","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2008.01.007_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","article-title":"Validation of the anthrax lethal toxin neutralization assay","volume":"32","author":"Hering","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.jim.2008.01.007_bib16","first-page":"35","article-title":"Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin","volume":"31","author":"Huber","year":"2005","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.jim.2008.01.007_bib17","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.vaccine.2005.01.013","article-title":"Human-derived, plant-produced monoclonal antibody for the treatment of anthrax","volume":"23","author":"Hull","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2008.01.007_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/infdis\/118.1.97","article-title":"Neurological and physiological responses of the primate to anthrax infection","volume":"118","author":"Klein","year":"1968","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2008.01.007_bib51","series-title":"The Comprehensive Sourcebook of Bacterial Protein Toxins","first-page":"243","article-title":"The bifactorial Bacillus anthracis lethal and oedema toxins","author":"Leppla","year":"1999"},{"key":"10.1016\/j.jim.2008.01.007_bib20","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib22","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1128\/IAI.73.10.6547-6551.2005","article-title":"An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin","volume":"73","author":"Lim","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI17991","article-title":"Bacillus anthracis lethal toxin induces TNF-\u03b1-independent hypoxia-mediated toxicity in mice","volume":"112","author":"Moayeri","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2008.01.007_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/bi015860m","article-title":"Stoichiometry of anthrax toxin complexes","volume":"41","author":"Mogridge","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jim.2008.01.007_bib25","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib26","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib27","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CDLI.12.6.713-721.2005","article-title":"Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis","volume":"12","author":"Pittman","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2008.01.007_bib29","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1016\/j.vaccine.2006.01.054","article-title":"Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series","volume":"24","author":"Pittman","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib30","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/JCM.32.10.2441-2447.1994","article-title":"Determination of parallelism and nonparallelism in bioassay dilution curves","volume":"32","author":"Plikaytis","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2008.01.007_bib31","doi-asserted-by":"crossref","first-page":"20124","DOI":"10.1016\/S0021-9258(18)54899-7","article-title":"Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis","volume":"266","author":"Quinn","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2008.01.007_bib32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2008.01.007_bib33","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax","volume":"190","author":"Quinn","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2008.01.007_bib34","first-page":"S68","volume":"vol. 45","author":"Russell","year":"2007"},{"key":"10.1016\/j.jim.2008.01.007_bib35","first-page":"869","article-title":"A new approach for clinical biological assay comparison and standardization: application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits","volume":"6","author":"Rymer","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jim.2008.01.007_bib36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CDLI.11.5.919-923.2004","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum","volume":"11","author":"Semenova","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2008.01.007_bib37","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.vaccine.2006.11.028","article-title":"Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax","volume":"25","author":"Semenova","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2008.01.007_bib38","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/IAI.67.4.1853-1859.1999","article-title":"Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells","volume":"67","author":"Singh","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib39","first-page":"2003","article-title":"Novel mathematical approach to TNA endpoints","volume":"vol. 4","author":"Taylor","year":"2003"},{"key":"10.1016\/j.jim.2008.01.007_bib40","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1128\/IAI.67.6.3055-3060.1999","article-title":"Proteasome activity is required for anthrax lethal toxin to kill macrophages","volume":"67","author":"Tang","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib54","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/IAI.01632-06","article-title":"Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis","volume":"75","author":"Tessier","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/infdis\/118.1.85","article-title":"Neurological and physiological responses of the primate to anthrax toxin","volume":"118","author":"Vick","year":"1968","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2008.01.007_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/HAB-2004-13402","article-title":"Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly","volume":"13","author":"Wang","year":"2004","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.jim.2008.01.007_bib43","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.jim.2008.01.007_bib44","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2008.01.007_bib45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jpba.2006.07.050","article-title":"Development and validation of a quantitative cell-based bioassay for comparing the pharmacokinetic profiles of two recombinant erythropoietic proteins in serum","volume":"43","author":"Wei","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jim.2008.01.007_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biocel.2006.08.010","article-title":"Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses","volume":"39","author":"Xu","year":"2007","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.jim.2008.01.007_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jim.2004.12.022","article-title":"Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen","volume":"298","author":"Zmuda","year":"2005","journal-title":"J. Immunol. Methods"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175908000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175908000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T03:30:14Z","timestamp":1630726214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175908000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0022175908000276"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2008.01.007","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}